High Expression of KCa3.1 in Patients with Clear Cell Renal Carcinoma Predicts High Metastatic Risk and Poor Survival

por Rabjerg, Maj, Oliván-Viguera, Aida, Hansen, Lars Koch, Jensen, Line, Sevelsted-Møller, Linda, Walter, Steen, Jensen, Boye L., Marcussen, Niels, Köhler, Ralf
Publicado 2015

Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels

por Lambertsen, Kate Lykke, Gramsbergen, Jan Bert, Sivasaravanaparan, Mithula, Ditzel, Nicholas, Sevelsted-Møller, Linda Maria, Oliván-Viguera, Aida, Rabjerg, Maj, Wulff, Heike, Köhler, Ralf
Publicado 2012

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury

por Sevelsted Møller, Linda, Fialla, Annette Dam, Schierwagen, Robert, Biagini, Matteo, Liedtke, Christian, Laleman, Wim, Klein, Sabine, Reul, Winfried, Koch Hansen, Lars, Rabjerg, Maj, Singh, Vikrant, Surra, Joaquin, Osada, Jesus, Reinehr, Roland, de Muckadell, Ove B. Schaffalitzky, Köhler, Ralf, Trebicka, Jonel
Publicado 2016